s6y
Company name or ticker
Search
Orexigen Therapeutics, Inc.
SC 13G
Foresite Capital Fund III, L.P.: Major shareholder report (passive investor)
Filed
Tuesday, August 4, 2015
Accession number
0001144204-15-046001
Documents
Schedule 13G
SC 13G
On sec.gov
Filing index
All files
Complete submission text
SGML header